KLOW
The architecture of skin, rebuilt from inside.
Includes syringes & alcohol pads
HPLC-verified ≥99% purity · Certificate of Analysis
Four molecules, one blueprint for the structure of you.
KLOW is a blend — GHK-Cu, BPC-157, TB-500, and Matrixyl — formulated around a single idea: skin and connective tissue respond to molecular signals that tell them to rebuild. GHK-Cu is a copper peptide with extensive research in collagen synthesis and hair follicle signaling. BPC-157 and TB-500 bring the regenerative logic we know from recovery protocols. Matrixyl is the peptide cosmetic science has relied on for a decade.
Together, they address skin and connective tissue from inside the body — where topical peptides cannot reach.
Skin Remodeling
GHK-Cu and Matrixyl are researched for effects on collagen synthesis and dermal structure.
Connective Tissue
BPC-157 and TB-500 support the regenerative signaling of tendons and ligaments.
Hair Follicle Support
Copper peptides are studied for their role in hair follicle signaling.
Wound & Scar Response
The blend is researched for effects on healing quality and scar formation.
Reconstitution & Administration
Reconstitute with bacteriostatic water. The solution is blue-tinted from the copper in GHK-Cu — that's normal. Always store protected from light. Never combine in the same syringe with other peptides.
This information is for research context. Any decisions about personal use — including dosing, timing, and cycle length — should involve a licensed medical provider familiar with your individual health.
The Timeline
KLOW is typically dosed at 1mg daily on a 5-on / 2-off cycle, run for 30 days followed by a 2-week break. The solution is blue-tinted from the copper — that's the signature of GHK-Cu and is normal. Skin and hair effects unfold slowly; most users evaluate over 60–90 days.
Often paired with:
Questions, answered.
"The architecture is yours. These molecules help you remember the blueprint."
NAD+
The current beneath every cellular conversation.
MOTS-C
The signal your mitochondria send to the rest of you.
Retatrutide
Three receptors. One molecule. A new conversation with metabolism.
For research use only. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.